India Approves FabiSpray For COVID-19 Treatment

• Feb 10, 2022
• NewsBytes

Glenmark Pharmaceuticals has launched a nasal spray in India for the treatment of COVID-19 in adult patients.

• Glenmark
• FabiSpray
• Covid
• treatment
• medicine
• I

Glenmark Launches Favipiravir Medicine For COVID-19

• Jun 22, 2020
• NDTV

After receiving permission from Drugs Controller General of India (DCGI), Glenmark Pharmaceuticals launched the antiviral drug Favipiravir for the treatment of mild to moderate COVID-19 cases.

• Remdesivir
• Favipiravir
• Glenmark